Clinical trial
A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
NCT00501241 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
- Lead sponsor
- Procter and Gamble
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2007
- Completion date
- July 31, 2008
- Enrollment
- 214 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
chronic constipation